|
JBIO Jade Biosciences Inc 1798749 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-55,765,000.00 |
| Balance Sheet |
|
Current Assets
|
$471,251,000.00 |
|
Assets
|
$472,113,000.00 |
|
Current Liabilities
|
$31,570,000.00 |
|
Liabilities
|
$32,198,000.00 |
|
Equity
|
$439,915,000.00 |
|
Shares Out
|
63556065.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-67,737,000.00 |
|
Investing Cash Flow
|
$-106,102,000.00 |
| Market Analysis |
Market Cap
|
$1,349,295,259.95 |
|
Price
|
$21.23 |
|
BVPS
|
6.92 |
|
PB
|
3.07 |
|
EPS
|
-0.76 |
|
FCF
|
$-67,933,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:25 |
|
| Apr |
May |
Jun |
| 2026-03-06 |
-3.19 |
|
|
2026-05-07 |
-0.57 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.86 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.48 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view JBIO documents filed with the SEC.
JBIO Filings
Clear
